Apixaban and rivaroxaban are the oral anticoagulants most frequently used to treat acute venous thromboembolism. However, uncertainty remains about the difference in bleeding risk between the two ...
FDA Breakthrough-designated device under evaluation for treatment of life-threatening abdominal bleeding at leading U.S. trauma centers shows promising results in first patient Arsenal Medical, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results